Resolution of intravitreal clots by urokinase.
D000328:Adult; D000368:Aged; D000867:Anterior Chamber; D001778:Blood Coagulation Disorders; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D007267:Injections; D008297:Male; D008722:Methods; D008875:Middle Aged; D011183:Postoperative Complications; D012166:Retinal Hemorrhage / Q000188:drug therapy; D014605:Uveitis / Q000139:chemically induced; D014792:Visual Acuity; D014822:Vitreous Body
D005343:Fibrinolytic Agents